A global view on carbapenem-resistant Acinetobacter baumannii

A global view on carbapenem-resistant Acinetobacter baumannii

ABSTRACTTo give an update on the molecular epidemiology and global distribution of carbapenemase encoding genes, we subjected 313 carbapenem-resistant Acinetobacter baumannii isolated from 114 study centers in 47 countries in five world regions, Africa, Asia, Europe, Latin America, and North America...

Full description

Bibliographic Details
Main Authors:	Carina Müller, Sandra Reuter, Julia Wille, Kyriaki Xanthopoulou, Danuta Stefanik, Hajo Grundmann, Paul G. Higgins, Harald Seifert
Format:	Article
Language:	English
Published:	American Society for Microbiology 2023-12-01
Series:	mBio
Subjects:	Acinetobacter baumannii carbapenem resistance molecular epidemiology genome analysis carbapenemase international clone
Online Access:	https://journals.asm.org/doi/10.1128/mbio.02260-23

Similar Items

The H-NS Regulator Plays a Role in the Stress Induced by Carbapenemase Expression in Acinetobacter baumannii
by: Fanny Huang, et al.
Published: (2020-08-01)

Genotypes and β-Lactamase Gene Carriage in Carbapenem-Resistant Acinetobacter Baumannii Isolated in Moscow
by: I. V. Chebotar, et al.
Published: (2020-05-01)

The optimized carbapenem inactivation method for objective and accurate detection of carbapenemase-producing Acinetobacter baumannii
by: Sirui Zhang, et al.
Published: (2023-07-01)

Genotyping of carbapenem resistant Acinetobacter baumannii isolated from Egyptian patients
by: Heba Ahmed Mohamed, et al.
Published: (2022-12-01)

False-positive imipenemase detected by NG-Test CARBA-5 in carbapenem-resistant Acinetobacter baumannii
by: Emily Bentley, et al.
Published: (2024-01-01)

Indications of carbapenem resistance evolution through heteroresistance as an intermediate stage in Acinetobacter baumannii after carbapenem administration Indicações da evolução da resistência ao carbapenem através da heteroresistência como estágio intermediário no Acinetobacter baumannii após administração de carbapenem
by: Silvana Vargas Superti, et al.
Published: (2009-04-01)

Detection of Clonal Relationship Between Carbapenem-resistant Acinetobacter baumannii Isolates in an University Hospital
by: Yasemin KIRIK, et al.
Published: (2021-12-01)

Genomic epidemiology of Acinetobacter baumannii goes global
by: Santiago Castillo-Ramírez
Published: (2023-12-01)

Carbapenem Resistant Acinetobacter baumannii: Current Status of Problem in a Tertiary Care Hospital, Jaipur
by: Ekadashi Rajni, et al.
Published: (2023-06-01)

Effectiveness of Colistin in carbapenem resistant Acinetobacter baumannii – A systematic review
by: Feroz Ahmed, et al.
Published: (2023-09-01)

Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe
by: Ivana Goic-Barisic, et al.
Published: (2023-06-01)

A comparative study of genotyping and antimicrobial resistance between carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates at a tertiary pediatric hospital in China
by: Xiaoli Jian, et al.
Published: (2024-03-01)

Is It Possible to Eradicate Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) from Endemic Hospitals?
by: Filippo Medioli, et al.
Published: (2022-07-01)

Carbapenem-resistant Acinetobacter baumannii carrier detection: a simple and efficient protocol
by: Jonathan Lellouche, et al.
Published: (2024-04-01)

Occurrence of Acinetobacter baumannii genomic resistance islands (AbGRIs) in Acinetobacter baumannii strains belonging to global clone 2 obtained from COVID-19 patients
by: Ghazal Naderi, et al.
Published: (2023-08-01)

Hemorrhagic bronchitis caused by carbapenem-resistant Acinetobacter baumannii infection: A case report
by: Zifang Li, et al.
Published: (2024-01-01)

Phenotypic and molecular characterization of carbapenem-resistant Acinetobacter baumannii isolates from ventilator associated pneumonia patients
by: Rehab Rabie, et al.
Published: (2025-02-01)

Clinical and molecular features of NDM-producing Acinetobacter baumannii in a multicenter study in Israel
by: Amos Adler, et al.
Published: (2023-06-01)

NDM-1- and OXA-23-producing Acinetobacter baumannii in wastewater of a Nigerian hospital
by: Erkison Ewomazino Odih, et al.
Published: (2023-12-01)

Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii group in Taiwan
by: Tran Lam Tu Quyen, et al.
Published: (2025-01-01)

Epidemiological characteristics of carbapenem-resistant Enterobacteriaceae and carbapenem-resistant Acinetobacter baumannii in a tertiary referral hospital in Korea
by: Sollan Kang, et al.
Published: (2022-06-01)

Pharmacokinetic/pharmacodynamic (PK/PD) simulation for dosage optimization of colistin and sitafloxacin, alone and in combination, against carbapenem-, multidrug-, and colistin-resistant Acinetobacter baumannii
by: Vipavee Rodjun, et al.
Published: (2023-11-01)

Antimicrobial Susceptibility Pattern of Acinetobacter Baumannii and Rate of Carbapenem Resistance at a Tertiary Care Hospital in Karachi
by: Shomaila Malik, et al.
Published: (2017-06-01)

Detection of the blaVIM-2 Gene in Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates in Sudan
by: Salma Mohamed, et al.
Published: (2022-12-01)

Risk Factors for Development and Mortality of Bloodstream Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
by: Li L, et al.
Published: (2024-12-01)

Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii Infection
by: Du N, et al.
Published: (2024-08-01)

Transcriptomic investigations of polymyxins and colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii
by: Xingchen Bian, et al.
Published: (2024-12-01)

Characterisation of pellicle-forming ability in clinical carbapenem-resistant Acinetobacter baumannii
by: Heng Kang Ng, et al.
Published: (2023-05-01)

In vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance
by: Jacqueline Findlay, et al.
Published: (2022-09-01)

Effect of colistin-tigecycline combination on colistin-resistant and carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii
by: Suyeon Park, et al.
Published: (2025-02-01)

Four genotypes of carbapenem-resistant Acinetobacter baumannii strains lacking OXA-23 production in Korea
by: Young Ah Kim, et al.
Published: (2024-06-01)

In Silico Exploring of the Antibiotic Adjuvant Potential of some Natural Ligands in Carbapenem-Resistance Acinetobacter baumannii
by: Elaheh Zadeh Hosseingholi, et al.
Published: (2024-02-01)

Descriptive analysis of targeted carbapenemase genes and antibiotic susceptibility profiles among carbapenem-resistant Acinetobacter baumannii tested in the Antimicrobial Resistance Laboratory Network—United States, 2017–2020
by: Sarah Sabour, et al.
Published: (2024-02-01)

Prevalence of Carbapenemases in Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates from the Kingdom of Bahrain
by: Nouf Al-Rashed, et al.
Published: (2023-07-01)

Cefiderocol in Combating Carbapenem-Resistant <i>Acinetobacter baumannii</i>: Action and Resistance
by: Bahman Yousefi, et al.
Published: (2024-11-01)

Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumannii
by: Yu-Chia Hsieh, et al.
Published: (2020-01-01)

Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia
by: Chan Mi Lee, et al.
Published: (2022-12-01)

In-silico study of Lebanese herbal compounds against carbapenem-resistant Acinetobacter baumannii proteins
by: Israa Assaf, et al.
Published: (2023-01-01)

In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Tsung-Ying Yang, et al.
Published: (2021-08-01)

Adaptive resistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii (CRAB): microbiological and clinical issues
by: Anissa Desmoulin, et al.
Published: (2024-05-01)